Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: A wearable cardioverter-defibrillator (WCD) can terminate ventricular fibrillation and ventricular tachycardias via electrical shock and thus give transient protection from sudden cardiac death. We investigated its role after cardiac surgery.

Methods: We retrospectively analyzed all patients who were discharged with a WCD from cardiac surgery department. The WCD was prescribed for patients with a left ventricular ejection fraction (LVEF) of ≤35% or an explanted implantable cardioverter-defibrillator (ICD).

Results: A total of 100 patients were included in this study, the majority ( = 59) had received coronary artery bypass graft surgery. The median wearing time of a WCD patient was 23.5 hours per day. LVEF was 28.9 ± 8% after surgery and improved in the follow-up to 36.7 ± 11% ( < 0.001). Three patients were successfully defibrillated. Ten patients experienced ventricular tachycardias. No inappropriate shocks were given. An ICD was implanted in 25 patients after the WCD wearing period.

Conclusion: Ventricular arrhythmias occurred in 13% of the investigated patients. LVEF improved significantly after 3 months, and thus a permanent ICD implantation was avoided in several cases. Sternotomy did not impair wearing time of the WCD. A WCD can effectively protect patients against ventricular tachyarrhythmias after cardiac surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1660802DOI Listing

Publication Analysis

Top Keywords

wearable cardioverter-defibrillators
4
cardiac
4
cardioverter-defibrillators cardiac
4
cardiac surgery-a
4
surgery-a single-center
4
single-center experience
4
experience background
4
background wearable
4
wearable cardioverter-defibrillator
4
wcd
4

Similar Publications

Introduction: Occupational exposure to electromagnetic fields (EMF) is almost ubiquitous: workers with Active Implantable Medical Devices (AIMD) and Active Wearable Medical Devices (AWMD) are considered at particular risk with respect to occupational risk assessment and health surveillance (HS) procedures, due to possible electromagnetic hazards resulting in interference problems. The identification of these workers is therefore fundamental for prevention purposes. Aim of the study is to provide an estimate of the proportion of workers with AIMD and AWMD, and to list the main types of devices involved.

View Article and Find Full Text PDF

Machine learning (ML) approaches for propensity score estimation are increasingly used with the expectation of improving covariate balance and reducing bias, but their validity in selecting appropriate confounders remains controversial. In this study, we estimated the effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitor and angiotensin receptor blocker on all-cause mortality among heart failure patients with implantable cardioverter defibrillators in the U.S.

View Article and Find Full Text PDF

Sudden cardiac death (SCD) remains a pervasive public health challenge, accounting for a significant proportion of cardiac and all-cause mortality worldwide. Despite notable advancements in cardiovascular therapies and reductions in overall cardiac mortality, survival following sudden cardiac arrest (SCA) remains dismally low, and prediction strategies remain inadequate. This comprehensive review examines the current landscape of SCD etiologies and the latest guidelines for primary and secondary prevention of SCD with implantable cardioverter defibrillators (ICDs).

View Article and Find Full Text PDF

Introduction: With the ever-expanding increase in the availability of electronic devices that can monitor everything from a patient's daily step count to more detailed devices that can measure or estimate pulmonary artery pressures in patients with heart failure, the amount of data measured by these devices produces mountains of information.

Areas Covered: Our review will examine the various options and developments of both consumer-facing and professional medical devices. We discuss provider-facing cardiac devices including pacemakers, implantable cardioverter-defibrillators, Holter monitors, implantable loop recorders, left ventricular assist devices, patch monitors, and pulmonary artery pressure sensors, as well as consumer-facing cardiac medical devices including the Apple Watch and the Fitbit wearable device.

View Article and Find Full Text PDF

The objective of this study is to explore the current state of research concerning the cost-effectiveness of wearable health technologies, excluding hearing aids, owing to extensive previous investigation. A systematic review was performed using PubMed, EMBASE/MEDLINE, Google Scholar, and Cumulated Index to Nursing and Allied Health Literature to search studies evaluating the cost-effectiveness of wearable health devices in terms of quality-adjusted life years and incremental cost-effectiveness ratio. The search was conducted on March 28, 2023, and the date of publication did not limit the search.

View Article and Find Full Text PDF